Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFIA
|
ENSG00000162599.11 | nuclear factor I A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFIA | hg19_v2_chr1_+_61869748_61869782 | -0.64 | 1.3e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_41742697 | 5.98 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr2_-_31637560 | 5.61 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
chr13_-_20805109 | 3.82 |
ENST00000241124.6
|
GJB6
|
gap junction protein, beta 6, 30kDa |
chr4_-_57547454 | 2.54 |
ENST00000556376.2
|
HOPX
|
HOP homeobox |
chr4_-_57547870 | 2.53 |
ENST00000381260.3
ENST00000420433.1 ENST00000554144.1 ENST00000557328.1 |
HOPX
|
HOP homeobox |
chr2_-_113542063 | 2.30 |
ENST00000263339.3
|
IL1A
|
interleukin 1, alpha |
chrX_+_135251783 | 2.28 |
ENST00000394153.2
|
FHL1
|
four and a half LIM domains 1 |
chr10_+_102106829 | 2.27 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
chrX_+_135252050 | 2.19 |
ENST00000449474.1
ENST00000345434.3 |
FHL1
|
four and a half LIM domains 1 |
chr7_-_27135591 | 2.13 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
chrX_+_135251835 | 2.10 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
chr13_+_78109884 | 2.08 |
ENST00000377246.3
ENST00000349847.3 |
SCEL
|
sciellin |
chr5_+_135394840 | 2.07 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr16_-_55867146 | 2.06 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
chr16_-_55866997 | 2.04 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
chr13_+_78109804 | 2.01 |
ENST00000535157.1
|
SCEL
|
sciellin |
chr19_+_41725088 | 1.98 |
ENST00000301178.4
|
AXL
|
AXL receptor tyrosine kinase |
chr3_-_74570291 | 1.95 |
ENST00000263665.6
|
CNTN3
|
contactin 3 (plasmacytoma associated) |
chr10_-_100995540 | 1.93 |
ENST00000370546.1
ENST00000404542.1 |
HPSE2
|
heparanase 2 |
chr21_-_44846999 | 1.86 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
chr5_-_95018660 | 1.85 |
ENST00000395899.3
ENST00000274432.8 |
SPATA9
|
spermatogenesis associated 9 |
chr15_+_67458357 | 1.84 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
chr12_-_122238464 | 1.82 |
ENST00000546227.1
|
RHOF
|
ras homolog family member F (in filopodia) |
chr18_-_31802056 | 1.68 |
ENST00000538587.1
|
NOL4
|
nucleolar protein 4 |
chr3_+_52350335 | 1.60 |
ENST00000420323.2
|
DNAH1
|
dynein, axonemal, heavy chain 1 |
chr8_+_124194875 | 1.55 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
chr9_-_99064386 | 1.54 |
ENST00000375262.2
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3 |
chr11_-_58343319 | 1.53 |
ENST00000395074.2
|
LPXN
|
leupaxin |
chr2_+_102953608 | 1.51 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
chr18_+_61143994 | 1.51 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr12_+_57828521 | 1.51 |
ENST00000309668.2
|
INHBC
|
inhibin, beta C |
chr19_-_40324767 | 1.48 |
ENST00000601972.1
ENST00000430012.2 ENST00000323039.5 ENST00000348817.3 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
chr18_+_61254570 | 1.48 |
ENST00000344731.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr8_+_124194752 | 1.45 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
chr18_+_61254534 | 1.43 |
ENST00000269489.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr4_-_103266355 | 1.41 |
ENST00000424970.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr14_-_24732368 | 1.40 |
ENST00000544573.1
|
TGM1
|
transglutaminase 1 |
chr14_+_75746340 | 1.40 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr11_-_66675371 | 1.38 |
ENST00000393955.2
|
PC
|
pyruvate carboxylase |
chr2_-_190044480 | 1.37 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr5_-_43313574 | 1.36 |
ENST00000325110.6
ENST00000433297.2 |
HMGCS1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
chr3_-_47950745 | 1.34 |
ENST00000429422.1
|
MAP4
|
microtubule-associated protein 4 |
chr14_-_75079026 | 1.34 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
chr14_-_24732403 | 1.33 |
ENST00000206765.6
|
TGM1
|
transglutaminase 1 |
chr14_+_75746781 | 1.33 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr15_+_41549105 | 1.29 |
ENST00000560965.1
|
CHP1
|
calcineurin-like EF-hand protein 1 |
chr11_-_128392085 | 1.28 |
ENST00000526145.2
ENST00000531611.1 ENST00000319397.6 ENST00000345075.4 ENST00000535549.1 |
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
chr12_-_95510743 | 1.18 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chr14_-_64194745 | 1.17 |
ENST00000247225.6
|
SGPP1
|
sphingosine-1-phosphate phosphatase 1 |
chr1_+_209878182 | 1.13 |
ENST00000367027.3
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
chr3_+_19189946 | 1.12 |
ENST00000328405.2
|
KCNH8
|
potassium voltage-gated channel, subfamily H (eag-related), member 8 |
chr9_-_99064429 | 1.11 |
ENST00000375263.3
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3 |
chr13_-_40177261 | 1.05 |
ENST00000379589.3
|
LHFP
|
lipoma HMGIC fusion partner |
chr12_-_53207842 | 1.05 |
ENST00000458244.2
|
KRT4
|
keratin 4 |
chr18_-_31802282 | 1.04 |
ENST00000535475.1
|
NOL4
|
nucleolar protein 4 |
chr2_+_17721230 | 1.02 |
ENST00000457525.1
|
VSNL1
|
visinin-like 1 |
chr17_+_16120512 | 1.01 |
ENST00000581006.1
ENST00000584797.1 ENST00000498772.2 ENST00000225609.5 ENST00000395844.4 ENST00000477745.1 |
PIGL
|
phosphatidylinositol glycan anchor biosynthesis, class L |
chr2_+_136289030 | 0.98 |
ENST00000409478.1
ENST00000264160.4 ENST00000329971.3 ENST00000438014.1 |
R3HDM1
|
R3H domain containing 1 |
chr17_-_8113542 | 0.98 |
ENST00000578549.1
ENST00000535053.1 ENST00000582368.1 |
AURKB
|
aurora kinase B |
chr1_+_24646002 | 0.97 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr7_+_147830776 | 0.96 |
ENST00000538075.1
|
CNTNAP2
|
contactin associated protein-like 2 |
chr4_-_103266626 | 0.95 |
ENST00000356736.4
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr11_+_33037652 | 0.93 |
ENST00000311388.3
|
DEPDC7
|
DEP domain containing 7 |
chr17_-_72358001 | 0.91 |
ENST00000375366.3
|
BTBD17
|
BTB (POZ) domain containing 17 |
chr1_-_24469602 | 0.91 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
chr15_+_67418047 | 0.91 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
chr1_-_204116078 | 0.90 |
ENST00000367198.2
ENST00000452983.1 |
ETNK2
|
ethanolamine kinase 2 |
chr12_-_53171128 | 0.89 |
ENST00000332411.2
|
KRT76
|
keratin 76 |
chr19_-_13227534 | 0.87 |
ENST00000588229.1
ENST00000357720.4 |
TRMT1
|
tRNA methyltransferase 1 homolog (S. cerevisiae) |
chr8_+_32579341 | 0.86 |
ENST00000519240.1
ENST00000539990.1 |
NRG1
|
neuregulin 1 |
chr19_-_13227463 | 0.86 |
ENST00000437766.1
ENST00000221504.8 |
TRMT1
|
tRNA methyltransferase 1 homolog (S. cerevisiae) |
chr8_-_131399110 | 0.85 |
ENST00000521426.1
|
ASAP1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
chr12_-_10251603 | 0.84 |
ENST00000457018.2
|
CLEC1A
|
C-type lectin domain family 1, member A |
chr19_-_43969796 | 0.83 |
ENST00000244333.3
|
LYPD3
|
LY6/PLAUR domain containing 3 |
chr13_-_36050819 | 0.83 |
ENST00000379919.4
|
MAB21L1
|
mab-21-like 1 (C. elegans) |
chr19_-_40324255 | 0.83 |
ENST00000593685.1
ENST00000600611.1 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
chr6_-_30658745 | 0.82 |
ENST00000376420.5
ENST00000376421.5 |
NRM
|
nurim (nuclear envelope membrane protein) |
chr10_+_105005644 | 0.81 |
ENST00000441178.2
|
RP11-332O19.5
|
ribulose-5-phosphate-3-epimerase-like 1 |
chr17_-_39661849 | 0.81 |
ENST00000246635.3
ENST00000336861.3 ENST00000587544.1 ENST00000587435.1 |
KRT13
|
keratin 13 |
chr6_-_32784687 | 0.81 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
chr16_-_79634595 | 0.81 |
ENST00000326043.4
ENST00000393350.1 |
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr12_-_28125638 | 0.80 |
ENST00000545234.1
|
PTHLH
|
parathyroid hormone-like hormone |
chr4_-_103266219 | 0.80 |
ENST00000394833.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr4_+_166248775 | 0.80 |
ENST00000261507.6
ENST00000507013.1 ENST00000393766.2 ENST00000504317.1 |
MSMO1
|
methylsterol monooxygenase 1 |
chr5_-_77844974 | 0.80 |
ENST00000515007.2
|
LHFPL2
|
lipoma HMGIC fusion partner-like 2 |
chr6_-_155776966 | 0.80 |
ENST00000159060.2
|
NOX3
|
NADPH oxidase 3 |
chr20_-_57607347 | 0.80 |
ENST00000395663.1
ENST00000395659.1 ENST00000243997.3 |
ATP5E
|
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
chr16_+_8891670 | 0.79 |
ENST00000268261.4
ENST00000539622.1 ENST00000569958.1 ENST00000537352.1 |
PMM2
|
phosphomannomutase 2 |
chr10_+_135340859 | 0.78 |
ENST00000252945.3
ENST00000421586.1 ENST00000418356.1 |
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1 |
chr5_+_147648393 | 0.78 |
ENST00000511106.1
ENST00000398450.4 |
SPINK13
|
serine peptidase inhibitor, Kazal type 13 (putative) |
chr22_-_38699003 | 0.78 |
ENST00000451964.1
|
CSNK1E
|
casein kinase 1, epsilon |
chr3_-_37216055 | 0.74 |
ENST00000336686.4
|
LRRFIP2
|
leucine rich repeat (in FLII) interacting protein 2 |
chrX_+_12924732 | 0.74 |
ENST00000218032.6
ENST00000311912.5 |
TLR8
|
toll-like receptor 8 |
chr19_+_41725140 | 0.73 |
ENST00000359092.3
|
AXL
|
AXL receptor tyrosine kinase |
chr12_+_56435637 | 0.72 |
ENST00000356464.5
ENST00000552361.1 |
RPS26
|
ribosomal protein S26 |
chr10_+_5005598 | 0.71 |
ENST00000442997.1
|
AKR1C1
|
aldo-keto reductase family 1, member C1 |
chr1_+_107683644 | 0.71 |
ENST00000370067.1
|
NTNG1
|
netrin G1 |
chr17_-_38657849 | 0.71 |
ENST00000254051.6
|
TNS4
|
tensin 4 |
chr2_-_228028829 | 0.71 |
ENST00000396625.3
ENST00000329662.7 |
COL4A4
|
collagen, type IV, alpha 4 |
chr12_-_10251576 | 0.70 |
ENST00000315330.4
|
CLEC1A
|
C-type lectin domain family 1, member A |
chr6_+_42989344 | 0.70 |
ENST00000244496.5
|
RRP36
|
ribosomal RNA processing 36 homolog (S. cerevisiae) |
chr1_-_155224699 | 0.69 |
ENST00000491082.1
|
FAM189B
|
family with sequence similarity 189, member B |
chr17_+_19314505 | 0.69 |
ENST00000461366.1
|
RNF112
|
ring finger protein 112 |
chr3_+_132843652 | 0.69 |
ENST00000508711.1
|
TMEM108
|
transmembrane protein 108 |
chr10_+_5238793 | 0.69 |
ENST00000263126.1
|
AKR1C4
|
aldo-keto reductase family 1, member C4 |
chr17_+_7323634 | 0.69 |
ENST00000323675.3
|
SPEM1
|
spermatid maturation 1 |
chr12_-_99038732 | 0.69 |
ENST00000393042.3
ENST00000420861.1 ENST00000299157.4 ENST00000342502.2 |
IKBIP
|
IKBKB interacting protein |
chr9_+_27109133 | 0.68 |
ENST00000519097.1
ENST00000380036.4 |
TEK
|
TEK tyrosine kinase, endothelial |
chr7_+_129015484 | 0.68 |
ENST00000490911.1
|
AHCYL2
|
adenosylhomocysteinase-like 2 |
chr11_+_193065 | 0.67 |
ENST00000342878.2
|
SCGB1C1
|
secretoglobin, family 1C, member 1 |
chr1_+_86934526 | 0.67 |
ENST00000394711.1
|
CLCA1
|
chloride channel accessory 1 |
chr14_+_96722539 | 0.67 |
ENST00000553356.1
|
BDKRB1
|
bradykinin receptor B1 |
chr11_+_34654011 | 0.66 |
ENST00000531794.1
|
EHF
|
ets homologous factor |
chr10_+_74653330 | 0.66 |
ENST00000334011.5
|
OIT3
|
oncoprotein induced transcript 3 |
chr1_+_107683436 | 0.66 |
ENST00000370068.1
|
NTNG1
|
netrin G1 |
chr11_-_113577014 | 0.65 |
ENST00000544634.1
ENST00000539732.1 ENST00000538770.1 ENST00000536856.1 ENST00000544476.1 |
TMPRSS5
|
transmembrane protease, serine 5 |
chr4_+_93225550 | 0.65 |
ENST00000282020.4
|
GRID2
|
glutamate receptor, ionotropic, delta 2 |
chr11_-_113577052 | 0.64 |
ENST00000540540.1
ENST00000545579.1 ENST00000538955.1 ENST00000299882.5 |
TMPRSS5
|
transmembrane protease, serine 5 |
chr18_+_61144160 | 0.64 |
ENST00000489441.1
ENST00000424602.1 |
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr17_-_39769005 | 0.64 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr10_-_75226166 | 0.63 |
ENST00000544628.1
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme |
chr4_+_144354644 | 0.62 |
ENST00000512843.1
|
GAB1
|
GRB2-associated binding protein 1 |
chr12_+_113682066 | 0.62 |
ENST00000392569.4
ENST00000552542.1 |
TPCN1
|
two pore segment channel 1 |
chr4_-_157892055 | 0.62 |
ENST00000422544.2
|
PDGFC
|
platelet derived growth factor C |
chr3_+_152017924 | 0.62 |
ENST00000465907.2
ENST00000492948.1 ENST00000485509.1 ENST00000464596.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr17_-_39093672 | 0.61 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
chr18_+_29171689 | 0.61 |
ENST00000237014.3
|
TTR
|
transthyretin |
chr10_+_24528108 | 0.61 |
ENST00000438429.1
|
KIAA1217
|
KIAA1217 |
chr15_+_74165945 | 0.60 |
ENST00000535547.2
ENST00000300504.2 ENST00000562056.1 |
TBC1D21
|
TBC1 domain family, member 21 |
chr7_-_27183263 | 0.60 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr9_+_17134980 | 0.59 |
ENST00000380647.3
|
CNTLN
|
centlein, centrosomal protein |
chr14_+_73704201 | 0.59 |
ENST00000340738.5
ENST00000427855.1 ENST00000381166.3 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
chr15_+_81475047 | 0.59 |
ENST00000559388.1
|
IL16
|
interleukin 16 |
chr3_-_194188956 | 0.58 |
ENST00000256031.4
ENST00000446356.1 |
ATP13A3
|
ATPase type 13A3 |
chr7_+_129932974 | 0.58 |
ENST00000445470.2
ENST00000222482.4 ENST00000492072.1 ENST00000473956.1 ENST00000493259.1 ENST00000486598.1 |
CPA4
|
carboxypeptidase A4 |
chr17_+_54671047 | 0.58 |
ENST00000332822.4
|
NOG
|
noggin |
chr9_-_98784042 | 0.58 |
ENST00000412122.2
|
LINC00092
|
long intergenic non-protein coding RNA 92 |
chr7_-_105319536 | 0.57 |
ENST00000477775.1
|
ATXN7L1
|
ataxin 7-like 1 |
chr22_-_48943199 | 0.57 |
ENST00000407505.3
|
CTA-299D3.8
|
Uncharacterized protein |
chr12_+_93965609 | 0.56 |
ENST00000549887.1
ENST00000551556.1 |
SOCS2
|
suppressor of cytokine signaling 2 |
chr2_+_33701286 | 0.56 |
ENST00000403687.3
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr5_-_44388899 | 0.56 |
ENST00000264664.4
|
FGF10
|
fibroblast growth factor 10 |
chr3_-_192635943 | 0.56 |
ENST00000392452.2
|
MB21D2
|
Mab-21 domain containing 2 |
chr7_+_134528635 | 0.55 |
ENST00000445569.2
|
CALD1
|
caldesmon 1 |
chr8_+_38586068 | 0.55 |
ENST00000443286.2
ENST00000520340.1 ENST00000518415.1 |
TACC1
|
transforming, acidic coiled-coil containing protein 1 |
chr10_+_11206925 | 0.55 |
ENST00000354440.2
ENST00000315874.4 ENST00000427450.1 |
CELF2
|
CUGBP, Elav-like family member 2 |
chr7_-_19184929 | 0.54 |
ENST00000275461.3
|
FERD3L
|
Fer3-like bHLH transcription factor |
chrX_+_49832231 | 0.54 |
ENST00000376108.3
|
CLCN5
|
chloride channel, voltage-sensitive 5 |
chr3_+_111718173 | 0.54 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
chr19_-_13710678 | 0.53 |
ENST00000592864.1
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr1_+_11539204 | 0.53 |
ENST00000294484.6
ENST00000389575.3 |
PTCHD2
|
patched domain containing 2 |
chr10_+_99609996 | 0.53 |
ENST00000370602.1
|
GOLGA7B
|
golgin A7 family, member B |
chr4_+_74269956 | 0.52 |
ENST00000295897.4
ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB
|
albumin |
chr19_+_41256764 | 0.52 |
ENST00000243563.3
ENST00000601253.1 ENST00000597353.1 ENST00000599362.1 |
SNRPA
|
small nuclear ribonucleoprotein polypeptide A |
chr2_+_30569506 | 0.52 |
ENST00000421976.2
|
AC109642.1
|
AC109642.1 |
chr20_+_42965626 | 0.52 |
ENST00000217043.2
|
R3HDML
|
R3H domain containing-like |
chr9_-_72287191 | 0.52 |
ENST00000265381.4
|
APBA1
|
amyloid beta (A4) precursor protein-binding, family A, member 1 |
chr11_-_2170786 | 0.52 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr15_+_38544476 | 0.51 |
ENST00000299084.4
|
SPRED1
|
sprouty-related, EVH1 domain containing 1 |
chr12_+_56521840 | 0.51 |
ENST00000394048.5
|
ESYT1
|
extended synaptotagmin-like protein 1 |
chr4_-_76928641 | 0.51 |
ENST00000264888.5
|
CXCL9
|
chemokine (C-X-C motif) ligand 9 |
chr10_-_104597286 | 0.50 |
ENST00000369887.3
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1 |
chrX_+_37639302 | 0.50 |
ENST00000545017.1
ENST00000536160.1 |
CYBB
|
cytochrome b-245, beta polypeptide |
chr19_+_49258775 | 0.49 |
ENST00000593756.1
|
FGF21
|
fibroblast growth factor 21 |
chr19_-_46296011 | 0.49 |
ENST00000377735.3
ENST00000270223.6 |
DMWD
|
dystrophia myotonica, WD repeat containing |
chr6_+_22569784 | 0.49 |
ENST00000510882.2
|
HDGFL1
|
hepatoma derived growth factor-like 1 |
chr10_+_74033672 | 0.49 |
ENST00000307365.3
|
DDIT4
|
DNA-damage-inducible transcript 4 |
chr22_+_24990746 | 0.49 |
ENST00000456869.1
ENST00000411974.1 |
GGT1
|
gamma-glutamyltransferase 1 |
chr20_-_14318248 | 0.49 |
ENST00000378053.3
ENST00000341420.4 |
FLRT3
|
fibronectin leucine rich transmembrane protein 3 |
chr3_-_171177852 | 0.49 |
ENST00000284483.8
ENST00000475336.1 ENST00000357327.5 ENST00000460047.1 ENST00000488470.1 ENST00000470834.1 |
TNIK
|
TRAF2 and NCK interacting kinase |
chr16_-_19725899 | 0.49 |
ENST00000567367.1
|
KNOP1
|
lysine-rich nucleolar protein 1 |
chr3_-_52002403 | 0.49 |
ENST00000490063.1
ENST00000468324.1 ENST00000497653.1 ENST00000484633.1 |
PCBP4
|
poly(rC) binding protein 4 |
chr4_+_156824840 | 0.48 |
ENST00000536354.2
|
TDO2
|
tryptophan 2,3-dioxygenase |
chr16_-_58328923 | 0.48 |
ENST00000567164.1
ENST00000219301.4 ENST00000569727.1 |
PRSS54
|
protease, serine, 54 |
chr18_+_59000815 | 0.47 |
ENST00000262717.4
|
CDH20
|
cadherin 20, type 2 |
chr2_-_219925189 | 0.47 |
ENST00000295731.6
|
IHH
|
indian hedgehog |
chr12_-_131200810 | 0.47 |
ENST00000536002.1
ENST00000544034.1 |
RIMBP2
RP11-662M24.2
|
RIMS binding protein 2 RP11-662M24.2 |
chr8_+_97597148 | 0.47 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
chr19_+_36249057 | 0.47 |
ENST00000301165.5
ENST00000536950.1 ENST00000537459.1 ENST00000421853.2 |
C19orf55
|
chromosome 19 open reading frame 55 |
chr16_-_58328870 | 0.47 |
ENST00000543437.1
|
PRSS54
|
protease, serine, 54 |
chr6_+_69942298 | 0.46 |
ENST00000238918.8
|
BAI3
|
brain-specific angiogenesis inhibitor 3 |
chr19_-_15560730 | 0.46 |
ENST00000389282.4
ENST00000263381.7 |
WIZ
|
widely interspaced zinc finger motifs |
chr14_-_98444461 | 0.46 |
ENST00000499006.2
|
C14orf64
|
chromosome 14 open reading frame 64 |
chr19_+_41257084 | 0.46 |
ENST00000601393.1
|
SNRPA
|
small nuclear ribonucleoprotein polypeptide A |
chr14_+_23299088 | 0.45 |
ENST00000355151.5
ENST00000397496.3 ENST00000555345.1 ENST00000432849.3 ENST00000553711.1 ENST00000556465.1 ENST00000397505.2 ENST00000557221.1 ENST00000311892.6 ENST00000556840.1 ENST00000555536.1 |
MRPL52
|
mitochondrial ribosomal protein L52 |
chr14_+_93897199 | 0.45 |
ENST00000553484.1
|
UNC79
|
unc-79 homolog (C. elegans) |
chr3_+_119013185 | 0.45 |
ENST00000264245.4
|
ARHGAP31
|
Rho GTPase activating protein 31 |
chr13_-_46716969 | 0.45 |
ENST00000435666.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr19_+_33463210 | 0.45 |
ENST00000590281.1
|
C19orf40
|
chromosome 19 open reading frame 40 |
chr4_+_169552748 | 0.45 |
ENST00000504519.1
ENST00000512127.1 |
PALLD
|
palladin, cytoskeletal associated protein |
chr4_-_114900831 | 0.45 |
ENST00000315366.7
|
ARSJ
|
arylsulfatase family, member J |
chr19_+_49259325 | 0.45 |
ENST00000222157.3
|
FGF21
|
fibroblast growth factor 21 |
chr12_+_56324933 | 0.45 |
ENST00000549629.1
ENST00000555218.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr3_-_47934234 | 0.44 |
ENST00000420772.2
|
MAP4
|
microtubule-associated protein 4 |
chr14_-_95236551 | 0.44 |
ENST00000238558.3
|
GSC
|
goosecoid homeobox |
chr3_+_101498074 | 0.44 |
ENST00000273347.5
ENST00000474165.1 |
NXPE3
|
neurexophilin and PC-esterase domain family, member 3 |
chr3_+_101498269 | 0.44 |
ENST00000491511.2
|
NXPE3
|
neurexophilin and PC-esterase domain family, member 3 |
chrX_+_105192423 | 0.44 |
ENST00000540278.1
|
NRK
|
Nik related kinase |
chr1_-_203320617 | 0.44 |
ENST00000354955.4
|
FMOD
|
fibromodulin |
chr5_+_122847908 | 0.43 |
ENST00000511130.2
ENST00000512718.3 |
CSNK1G3
|
casein kinase 1, gamma 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.4 | 5.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
1.0 | 4.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.9 | 2.7 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.8 | 2.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 2.8 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.5 | 1.4 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.5 | 1.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.5 | 3.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.4 | 1.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.4 | 2.3 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) |
0.4 | 2.6 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.4 | 1.9 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 0.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 2.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 1.0 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.3 | 1.8 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 1.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.3 | 3.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 0.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.3 | 1.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 3.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 1.5 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 1.4 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.2 | 2.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 5.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 1.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.9 | GO:1904640 | response to methionine(GO:1904640) |
0.2 | 0.6 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.2 | 0.7 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.5 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.2 | 0.5 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 0.5 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.2 | 0.8 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.2 | 0.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.2 | 1.3 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.4 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.1 | 0.4 | GO:0036309 | protein localization to M-band(GO:0036309) regulation of SA node cell action potential(GO:0098907) |
0.1 | 0.4 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.6 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.1 | 0.9 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.5 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 0.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.8 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.8 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 1.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.9 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 0.5 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.1 | 0.4 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.1 | 1.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.6 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.3 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 1.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.3 | GO:0001080 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.1 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 1.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:0050883 | negative regulation of sodium:proton antiporter activity(GO:0032416) musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.3 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 6.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 1.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 0.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.5 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.6 | GO:0071964 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) regulation of barbed-end actin filament capping(GO:2000812) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.1 | 0.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 1.6 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.9 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 3.8 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.3 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.3 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.3 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 0.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.1 | 1.0 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 0.2 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 1.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 2.4 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.3 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.3 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 1.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.5 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.3 | GO:0097021 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
0.0 | 0.2 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 1.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.6 | GO:0018394 | peptidyl-lysine acetylation(GO:0018394) |
0.0 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 2.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 1.0 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 1.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 4.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.2 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.0 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.7 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 1.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.0 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.1 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.0 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.8 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 1.0 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.1 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.4 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.0 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.3 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.0 | 1.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 2.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 2.7 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.0 | 0.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.6 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 6.7 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.7 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.5 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.4 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.7 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.2 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.5 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.1 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.1 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.2 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.1 | GO:1903027 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) regulation of opsonization(GO:1903027) |
0.0 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.0 | 0.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 1.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.3 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 2.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.3 | 2.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 0.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 3.8 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 2.7 | GO:0033643 | host cell part(GO:0033643) |
0.1 | 0.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 1.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 7.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 3.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.7 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 3.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 1.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 2.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 2.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 0.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 0.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 1.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.2 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.3 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 3.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 1.8 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 5.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 2.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.8 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 1.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 7.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.8 | 4.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.6 | 5.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.6 | 2.3 | GO:0030305 | heparanase activity(GO:0030305) |
0.6 | 2.8 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.5 | 1.5 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.5 | 1.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.5 | 2.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.4 | 2.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 1.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.4 | 1.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 2.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.7 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.2 | 0.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.2 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.2 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.5 | GO:0070984 | SET domain binding(GO:0070984) |
0.2 | 0.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 1.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 1.4 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.1 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.3 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 1.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 1.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 0.3 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 2.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 2.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 3.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 1.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 2.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.2 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 1.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 1.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.8 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0004609 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) phosphatidylserine decarboxylase activity(GO:0004609) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 2.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 4.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.0 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 4.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 1.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.1 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 1.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 1.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.6 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 1.1 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 1.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 1.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 2.5 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 5.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 6.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 2.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 2.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 3.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 1.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 4.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 5.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 7.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 5.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 3.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 3.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 3.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 1.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 1.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 2.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 1.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 2.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 1.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 2.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |